ESOP Compensation Committee in India: Governance Guide

An ESOP scheme approved by shareholders is an enabling document, not an operating system. The shareholder resolution authorises the pool. It says nothing about who decides which employees get grants, at what price, through what paper trail, or what happens when an employee disputes their leaver classification. Every one of those decisions belongs to the compensation committee, and the compensation committee exists on paper in most Indian startups while operating nowhere in practice. This article builds the operating layer from scratch: committee formation, charter design, grant approval workflow, register maintenance, and leaver clause governance.

What does an ESOP compensation committee actually do in an Indian private company?

The compensation committee is the administrative authority for a live ESOP scheme. It approves individual grants, verifies eligibility, confirms FMV valuation timing, interprets leaver clause disputes, and oversees pool utilisation against the shareholder-approved limit. For listed companies, the Securities and Exchange Board of India (SEBI) (Share Based Employee Benefits and Sweat Equity) Regulations, 2021 (SBEB Regulations) mandate this committee by statute. For private companies under the Companies Act, 2013, it is a governance best practice with no equivalent statutory mandate, which is precisely why most private company founders either skip it or create it without defining its authority.

Why the Companies Act framework is silent on committee governance

Section 62(1)(b) of the Companies Act, 2013, read with Rule 12 of the Companies (Share Capital and Debentures) Rules, 2014, governs what must be in a scheme document and how the scheme is approved. It does not prescribe how grants are made after approval. Rule 12(7) requires the company to maintain a register of options in Form SH-6. Rule 12(9) requires annual disclosure in the directors’ report. Beyond these filing requirements, the operational governance layer is entirely discretionary.

This silence is not a permission slip to ignore governance. It is an instruction to design it properly from the outset, because investors, acquirers, and tax authorities will reconstruct the governance trail from whatever documentation exists. If compensation committee resolutions do not exist, they will conclude that grants were made without process. That conclusion is expensive to reverse during a fundraise or an acquisition.

One material change to the framework is pending. The Corporate Laws (Amendment) Bill, 2026, introduced in the Lok Sabha on 23 March 2026 and currently under review by the Joint Parliamentary Committee, proposes to formally recognise Restricted Stock Units (RSUs) and Stock Appreciation Rights (SARs) by amending Section 62(1)(b) to cover “schemes linked to the value of share capital.” Until the subordinate Companies (Share Capital and Debentures) Rules, 2014 are updated to match, RSUs and SARs continue to be structured within the ESOP procedural framework, and the compensation committee’s authority extends to these instruments under the existing scheme.

How to structure the compensation committee for a private company

What is the minimum viable committee composition?

At the minimum, the compensation committee needs at least two directors. The board resolution forming the committee should name the members, define the quorum, and record the committee’s terms of reference. A resolution that simply states “a compensation committee is hereby formed” without specifying authority, quorum, and decision scope is administrative window dressing and provides no governance protection during diligence.

Once a company has independent directors on its board, which is typical from Series A onwards where investor board seats are commonly accompanied by an independent director requirement in the Shareholders’ Agreement, the committee should include at least one independent director. This is not a statutory requirement for private companies today, but it is the investor expectation, and building it in from the start avoids a rebuild during the next round.

For SEBI-regulated entities, the SBEB Regulations 2021 prescribe that the committee must consist primarily of independent directors. Private companies should treat this as a design target rather than a constraint. The principle of independent oversight of compensation decisions exists for good reason regardless of listing status.

What must the committee charter cover?

The committee charter is the document that defines what the committee can decide and what it must escalate. It is recorded in board minutes. Most startups never create one, which means the committee’s authority is undefined and every grant decision is potentially challengeable.

A working charter for a private company covers six things.

Grant authority thresholds. Define the maximum options that can be approved per grantee without full board sign-off. A practical threshold is 0.5% of fully diluted shares for senior hires and 0.25% for all others. Anything above these thresholds requires full board approval. Without this threshold, a co-founder can commit a large equity grant to a candidate during hiring negotiations and then document it retroactively after the committee meeting, which is the most common grant documentation failure we see at Treelife during diligence.

FMV valuation timing requirement. The charter must state that no grant letter is issued without a valuation report from a Category I Merchant Banker registered with SEBI, dated within the grant cycle. Rule 11UA of the Income Tax Rules, 1962 requires FMV certification for perquisite tax computation; the Income Tax Act does not permit backdated valuation reports. The committee charter making this a pre-condition for grant approval prevents the practical problem of grant letters being issued in advance of valuation support.

Grant window cadence. The committee operates on a defined schedule (quarterly or half-yearly grant windows are standard) rather than approving grants on an ad hoc basis per hire. Quarterly grant windows mean one valuation report per quarter covers all grants, keep committee meetings manageable, and produce a clean documentation trail. Ad hoc grant approvals produce fragmented records that are difficult to reconcile during diligence.

Modification authority. Any change to vesting schedules, exercise prices, or leaver terms on an existing grant requires committee approval and documented employee consent. The charter should state this explicitly. Informal post-grant “adjustments” are a frequent source of undocumented obligations that appear during diligence as ambiguous liabilities.

Leaver clause interpretation authority. The committee, not the HR function, decides how a separation is classified under the scheme’s leaver provisions. The charter must confer this authority expressly, and must specify the process for the employee to contest a classification. Without this, the person making the classification is whoever happens to manage the offboarding, which is not the right decision-maker for a determination that can affect the employee’s vested equity.

Pool utilisation review. The committee reviews pool utilisation at each meeting: options granted, options available, options that have lapsed, and the runway to pool exhaustion relative to the hiring plan. This prevents the recurring problem of pool overruns, where cumulative grants exceed the shareholder-approved pool without anyone noticing until a new investor runs the numbers during term sheet diligence.

Table: Compensation committee authority matrix

Decision type	Compensation committee	Full board	Shareholder resolution
Grant within approved pool, below single-employee threshold	Approve	Not required	Not required
Grant above single-employee threshold	Recommend	Approve	Not required
Grant exceeding 1% of issued share capital to one individual	Recommend	Recommend	Special resolution required under Rule 12(6)(b)
Pool expansion	Not applicable	Recommend	Special resolution required
Exercise price modification on existing grant	Approve	Note in minutes	Not required
Scheme amendment (material terms)	Recommend	Approve	Special resolution required
Leaver clause classification dispute	Decide	Escalate only if committee is deadlocked	Not applicable

The grant approval workflow: seven steps, seven documents

The gap between an approved ESOP scheme and a legally valid employee grant letter is seven steps. Every step generates a document that a diligence team will look for. Missing any one of them creates a gap that is expensive to remediate.

Step 1: Compensation committee meeting and resolution

The committee convenes (in person or through a valid written resolution) and approves the proposed grantees individually or by batch. The resolution records each grantee’s name, number of options, exercise price, vesting schedule, and the valuation report reference used to support the exercise price. Signed minutes from this meeting are the primary governance record for the grant.

Step 2: Eligibility verification against scheme terms

Before the resolution is finalised, the company secretary or legal counsel verifies that each proposed grantee is eligible under the scheme document: permanent employee status, not a promoter (unless the DPIIT exception applies), not holding more than 10% equity unless covered by the DPIIT startup carve-out, and not barred under any other scheme condition. This verification is documented as a note to the committee minutes or as a separate compliance confirmation.

Step 3: FMV valuation report

A Category I Merchant Banker registered with SEBI provides a valuation report using the DCF methodology prescribed under Rule 11UA. The report is dated within the grant window. No grant letter proceeds without this report. A valuation report dated after the grant letter creates a compliance breach regardless of whether the FMV figure would have been the same; the Income Tax Department will not accept an ex-post valuation as support for a perquisite computation.

Step 4: Grant letter issuance

Each grant letter specifies: the number of options granted, the exercise price, the specific ESOP scheme under which the grant is made, the grant date, the vesting schedule including the cliff period (minimum one year under Rule 12), the exercise window, and the treatment of options on separation. The grant letter is signed by an authorised signatory of the company and counter-signed by the employee. No legal entitlement exists without a signed letter; verbal or email commitments are not enforceable against the company under Section 62(1)(b).

Step 5: SH-6 register update

Rule 12(10) requires the company to maintain a register of employee stock options in Form SH-6. This register records every grant (employee name, date, number, exercise price, vesting schedule), every vesting event, every exercise, and every lapse or forfeiture. The register must be updated on the date of each grant, not retrospectively. Companies that reconstruct the SH-6 before a funding round diligence exercise consistently find discrepancies between the register, the grant letters, and the cap table. Those discrepancies require forensic reconciliation that adds weeks to a diligence timeline.

Step 6: Cap table update

Options are counted as dilutive on a fully diluted basis from the date of grant, not from vesting or exercise. The cap table must be updated to reflect each grant as soon as the grant letter is signed. Investors verify the fully diluted cap table against both MCA filings and the SH-6 register. A cap table that does not match either source is a diligence red flag regardless of the explanation.

Step 7: Annual disclosure in the directors’ report

Rule 12(9) requires the directors’ report to disclose ESOP scheme details annually: total options outstanding at the start and end of the year, options granted, vested, exercised, and lapsed during the year, the weighted average exercise price, and the method of valuation. This disclosure is part of the public record once filed as part of the annual return with the Registrar of Companies. Disclosures that do not match the SH-6 register are a compliance failure that surfaces during any structured review of public filings.

How should leaver clauses be governed, not just drafted?

The leaver clause determines what happens to an employee’s options when they leave. It is the provision that most scheme documents draft in good faith and then fail to operate correctly, because the operation of the clause requires a governance decision that the scheme document does not assign to anyone specific.

What are the standard leaver clause structures?

Good leaver treatment (voluntary resignation in good standing, retirement, death, disability) typically provides that unvested options lapse on the last working day and vested options are exercisable within a defined window after separation. That window ranges from 90 days in older schemes to 12 months in more employee-friendly designs. The 90-day window is the most common default, and it is also the one that creates the most disputes. An employee who leaves a pre-IPO company with high FMV options and a 90-day exercise window faces a cash-flow crisis: they must pay the exercise price and trigger perquisite tax on illiquid shares within three months of losing their salary. A 12-month window for good leavers is a more defensible design, and it costs the company nothing in dilution terms since the options are already vested.

Bad leaver treatment (termination for cause, fraud, material breach of employment terms) typically provides that all options, including vested options, lapse on the date of termination. Most employees focus on losing unvested options when they exit under bad leaver terms. The more significant risk is losing options that have already vested, which employees treat as earned and the company treats as discretionary. The scheme document must make the bad leaver consequence explicit and specific. A clause that says the company “may” cancel vested options on bad leaver termination creates ambiguity; a clause that says vested options “shall lapse” on the date of a bad leaver termination does not.

Who decides the classification, and how is it challenged?

This is the governance gap that most scheme documents leave unfilled. The answer should be: the compensation committee decides, using a defined process, with a documented right of the employee to contest the classification within a specified period. Without this, the HR function makes the call during offboarding, the employee contests it in correspondence with the founder, and the matter is never formally resolved. If the dispute surfaces during a later funding round or acquisition, the undocumented classification creates a contingent liability that the incoming investor’s counsel will flag.

The committee’s leaver classification process should include: written notice to the employee of the proposed classification and its equity consequences, a 10-day window for the employee to submit a written representation to the committee, a committee meeting (or written resolution) to consider the representation and issue a final determination, and notification of the determination to the employee in writing with reference to the specific scheme provision applied. This process takes two to three weeks and produces a paper trail that is defensible both internally and externally.

What ESOP governance failures cost founders at due diligence

The five patterns below appear repeatedly across the diligence exercises Treelife supports. Each is preventable with a functioning compensation committee calendar.

Grant letters issued before committee approval. Founders communicate equity commitments during offer negotiations or onboarding, and the documentation catches up later. The grant letter date precedes the committee resolution date. Backdated resolutions do not survive scrutiny and require employee notification and potentially a restatement of disclosed options in the annual report.

No valuation report at grant date. The FMV valuation was prepared for the fundraising round, not contemporaneously with the grant event. A valuation report that is six months older than the grant letter fails the Rule 11UA requirement and creates perquisite tax exposure for the employee, because the Income Tax Department can substitute its own FMV assessment. The difference between the company’s claimed FMV and the Department’s assessment is treated as additional perquisite income, with interest and penalty falling on the company as the TDS-deducting employer.

Pool utilisation not tracked against committee minutes. The scheme is approved for a 12% pool. Grants totalling 13.5% have been made over three years. The extra 1.5% was approved by the compensation committee without checking the cumulative count against the shareholder-approved limit. The excess grants have no shareholder resolution backing them. Remediation requires a fresh special resolution and retroactive disclosure in the directors’ report.

SH-6 not maintained contemporaneously. The company has 62 grant letters across four years and an SH-6 that was last updated in year one. Reconciling the register against the grant letters, the cap table, and the directors’ report disclosures is a forensic exercise that typically takes two to three weeks and surfaces discrepancies. Discrepancies trigger questions about the accuracy of all other representations.

Annual directors’ report disclosure that does not match the SH-6. This is almost always a consequence of the previous failure. The annual disclosure is prepared from a cap table spreadsheet rather than the SH-6 register, and the two records have diverged over time. Any investor’s legal counsel comparing the two will flag the mismatch immediately.

Treelife practitioner note

In the ESOP governance engagements we have run at Treelife, the most consistent finding is that the compensation committee exists on paper and nowhere else. Board minutes record its formation. The company cannot produce a single compensation committee resolution for any grant made in the preceding two to three years. Every grant was approved by a WhatsApp message from the founder or a line in the offer letter, and the grant letters were issued by HR without any committee process. This pattern is not limited to seed-stage companies; we see it regularly at Series B and Series C companies that set up their ESOP scheme to satisfy a term sheet condition and then treated administration as someone else’s problem.

The second pattern we see consistently is leaver clause disputes where no one is authorised to decide the outcome. A senior employee exits under circumstances that fall somewhere between the scheme’s good leaver and bad leaver definitions. The founder’s view and the employee’s view differ. There is no committee process to resolve this. The matter sits unresolved for months, the employee threatens litigation, and the dispute surfaces in the investor’s legal diligence at the next round as an undisclosed contingent liability.

The practice that separates well-governed ESOP programmes from poorly governed ones is structural, not technical: a quarterly compensation committee calendar with standing agenda items for grant approval, pool utilisation review, FMV valuation update, and leaver event resolution. Companies that run this calendar do not have diligence problems. Companies that do not, almost always do.

FAQs

Q: Is a compensation committee legally required for a private limited company in India?
A: No. The Companies Act, 2013 does not mandate a compensation committee for private companies. The requirement applies to listed companies under the SEBI SBEB Regulations, 2021. For private companies, the committee is a governance best practice that investors expect from Series A onwards, and its absence is a consistent diligence finding.

Q: What is the minimum number of directors required on an ESOP compensation committee?
A: Two directors is the workable minimum for a private company. The board resolution forming the committee should define quorum. Once the company has independent directors on its board, the committee should include at least one independent director as a governance standard, even though this is not a statutory requirement for private companies today.

Q: Who has authority to interpret leaver clauses when an employee disputes their classification?
A: The compensation committee should hold this authority expressly under its charter. Without a specific delegation, the classification defaults to whoever manages the offboarding, which is not the right governance level for a decision with equity consequences. The committee process should provide a written representation window for the employee before issuing a final determination.

Q: How often should the compensation committee meet?
A: Quarterly is the practical standard for a company with an active ESOP programme. Each meeting covers grant approvals for the quarter, pool utilisation review, FMV valuation status, and any pending leaver events. Companies with low grant activity can operate half-yearly, but the minimum is once before each grant cycle.

Q: Can the compensation committee approve grants above the single-employee threshold?
A: The threshold exists precisely to prevent this. Grants above the threshold defined in the committee charter (typically 0.5% of fully diluted capital for senior hires) should require full board approval after a committee recommendation. Grants exceeding 1% of issued share capital to a single individual require a separate special resolution under Rule 12(6)(b) of the Companies (Share Capital and Debentures) Rules, 2014 regardless of what the committee charter says.

Q: What is Form SH-6 and who is responsible for maintaining it?
A: Form SH-6 is the statutory register of employee stock options required under Rule 12(10) of the Companies (Share Capital and Debentures) Rules, 2014. It records every grant, vesting event, exercise, and lapse or forfeiture. It is maintained internally (not filed with the Registrar of Companies) and is typically the responsibility of the company secretary. It must be updated on the date of each event, not reconstructed retrospectively.

Q: What happens if the compensation committee approves grants that exceed the shareholder-approved pool?
A: The excess grants are not backed by a shareholder resolution and are therefore not validly authorised under Section 62(1)(b). Remediation requires a fresh special resolution from shareholders covering the excess and retroactive disclosure in the directors’ report. The process takes three to six weeks and typically surfaces as a diligence delay in a funding round.

Q: Does a new compensation committee resolution need to be passed for each grant, or can one resolution cover multiple grantees?
A: A single committee resolution can cover a batch of grants within the same grant window, provided each grantee is individually identified with their specific grant terms (number of options, exercise price, vesting schedule) in the resolution. A blanket resolution approving “grants to employees as determined by management” is not specific enough and will not survive scrutiny.

Q: Does the compensation committee need to be reconstituted if a board member resigns?
A: If the resigning board member was a committee member, the board should reconstitute the committee by resolution to maintain the minimum membership and quorum defined in the committee charter. Operating on a committee whose membership falls below quorum invalidates subsequent resolutions.

Q: What documents does an investor’s legal counsel typically request during ESOP diligence?
A: The standard ESOP diligence checklist covers: the ESOP scheme document, the shareholder resolution approving the scheme and any amendments, the MGT-14 filing confirming the resolution was filed with the Registrar of Companies, all compensation committee resolutions approving individual grants, all grant letters with employee signatures, FMV valuation reports for each grant cycle, the SH-6 register, Form PAS-3 filings for each exercise allotment, and annual ESOP disclosures in the directors’ reports for each year since scheme adoption.

Q: What is the relevance of the Corporate Laws (Amendment) Bill, 2026 to the compensation committee?
A: The Bill proposes to formally recognise RSUs and SARs within Section 62(1)(b) of the Companies Act. Once enacted and supported by updated subordinate rules, this will require compensation committees to administer multiple instrument types under a single governance framework. Companies already issuing RSUs should ensure their committee charter references the scheme instrument type explicitly and that grant documentation distinguishes between ESOPs and RSUs. The Bill is currently before the Joint Parliamentary Committee and has not yet been enacted as of the date of this article.

Q: What is the form that must be filed after shares are allotted on exercise?
A: Form PAS-3 (Return of Allotment) must be filed with the Registrar of Companies within 30 days of each allotment. Every exercise event that results in share issuance requires a fresh PAS-3. Companies that run annual exercise windows and do not file PAS-3 accumulate a public compliance gap in their MCA records that any investor’s legal counsel will find.

Q: How does the ESOP compensation committee interact with the broader board governance calendar?
A: The committee reports to the full board. Each committee meeting should produce minutes that are tabled at the next full board meeting for noting. Pool utilisation, significant grant decisions, and any leaver classification disputes should be summarised in the committee’s report to the board. This creates a clear audit trail from individual grant approval through board-level oversight.

Regulatory references:

• Section 62(1)(b), Companies Act, 2013 (statutory authority for ESOP issuance)
• Rule 12, Companies (Share Capital and Debentures) Rules, 2014 (procedural requirements)
• Rule 12(6)(b), Companies (Share Capital and Debentures) Rules, 2014 (special resolution for grants exceeding 1% of issued capital to one individual)
• Rule 12(9), Companies (Share Capital and Debentures) Rules, 2014 (annual directors’ report disclosure)
• Rule 12(10), Companies (Share Capital and Debentures) Rules, 2014 (SH-6 register requirement)